Top Section/Ad
Top Section/Ad
Most recent
◆ Praemia refis at a tighter coupon ◆ Schneider lands tight at the short end ◆ Minimal concessions needed
French biotech seeks to accelerate cancer vaccine program
◆ Single digit premiums offered ◆ Reverse Yankees dominating euro supply ◆ Floaters proving popular with multi-tranche issuers
Pair enjoyed strong execution and tight pricing as US high grade credit remained resilient in the face of a sell-off in equity markets
More articles/Ad
More articles/Ad
More articles
-
Medlive Technology and Brii Biosciences are tapping investors for a combined HK$6.7bn ($863m). -
South Korean pharmaceutical company HK Inno.N Corp has kicked off pre-deal investor education for its IPO, according to a source familiar with the matter.
-
The oil-rich nation took a blow from the global pandemic, but Kazakhstan is getting back on track
-
Kindstar Globalgene Technology and Dexin Services Group both rolled out their Hong Kong IPOs on Tuesday.
-
United Medical Group, the Russian healthcare company, has launched an IPO on the Moscow Exchange, which is expected to raise more than $500m, according to a source close to the transaction.
-
Personal hygiene company Ontex has launched a bond deal, aiming to replace the bulk of its previously secured capital structure with unsecured debt, and push out its 2022 maturity wall with longer-term funding.
